Could a common bile acid pill prevent brain fog after liver surgery?
NCT ID NCT07273734
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a bile acid pill (UDCA) to standard treatment can prevent a serious brain condition called hepatic encephalopathy after a liver procedure (TIPS). About 270 adults with cirrhosis will be randomly assigned to receive either UDCA plus lactulose or lactulose alone for 3 months. The goal is to see if the combination reduces episodes of confusion and disorientation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital, Sichuan University
Chengdu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Heart scans could flag Who's at risk after liver shunt
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant